DK200300114U3 - Faste tilstandsformer af ondansetron - Google Patents

Faste tilstandsformer af ondansetron Download PDF

Info

Publication number
DK200300114U3
DK200300114U3 DK200300114U DKBA200300114U DK200300114U3 DK 200300114 U3 DK200300114 U3 DK 200300114U3 DK 200300114 U DK200300114 U DK 200300114U DK BA200300114 U DKBA200300114 U DK BA200300114U DK 200300114 U3 DK200300114 U3 DK 200300114U3
Authority
DK
Denmark
Prior art keywords
ondansetron
base
solid
water
solution
Prior art date
Application number
DK200300114U
Other languages
Danish (da)
English (en)
Inventor
Westheim Raymond Joze Hubertus
Dalen Frans Van
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Application granted granted Critical
Publication of DK200300114U3 publication Critical patent/DK200300114U3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK200300114U 2003-01-09 2003-04-08 Faste tilstandsformer af ondansetron DK200300114U3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43878003P 2003-01-09 2003-01-09

Publications (1)

Publication Number Publication Date
DK200300114U3 true DK200300114U3 (da) 2004-04-23

Family

ID=23741979

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200300114U DK200300114U3 (da) 2003-01-09 2003-04-08 Faste tilstandsformer af ondansetron

Country Status (9)

Country Link
US (1) US20040198794A1 (fi)
EP (1) EP1581519A1 (fi)
AU (2) AU2003222765A1 (fi)
DK (1) DK200300114U3 (fi)
FI (1) FI6164U1 (fi)
FR (1) FR2849852A1 (fi)
GB (1) GB2398566A (fi)
NL (1) NL1022893C2 (fi)
WO (1) WO2004063189A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2238001B1 (es) 2004-01-21 2006-11-01 Vita Cientifica, S.L. Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
CA2565854A1 (en) 2004-05-07 2005-11-17 Taro Pharmaceutical Industries Ltd. Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
EP1828141A4 (en) * 2004-10-26 2009-04-01 Ipca Lab Ltd STAINING METHOD FOR PREPARING THE ANTIEMETIC 1,2,3,9-TETRAHYDRO-9-METHYL-3 - [(2-METHYL) -1H-IMIDAZOLE-1-YL) METHYL] -4H-CARBAZOLE-4-ON

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
NL190373C (nl) * 1984-01-25 1994-02-01 Glaxo Group Ltd Een 3-gesubstitueerde aminomethyl-2,3-dihydro-4(1h)-carbazolon, werkwijze ter bereiding daarvan, alsmede een farmaceutisch preparaat.
DE3680123D1 (en) * 1985-01-23 1991-08-14 Glaxo Group Ltd Tetrahydrocarbazolonderivate.
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
CA2106642C (en) * 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
EP1339707A2 (en) * 2000-10-30 2003-09-03 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
IL156835A0 (en) * 2001-01-11 2004-02-08 Teva Pharma An improved process for preparing pure ondansetron hydrochloride dihydrate
DE20320528U1 (de) * 2002-04-30 2004-09-16 Teva Pharmaceuticals Usa, Inc. Neue Kristallformen von Ondansetron und Arzneimittel, welche die neuen Formen enthalten

Also Published As

Publication number Publication date
FI6164U1 (fi) 2004-03-15
FR2849852A1 (fr) 2004-07-16
NL1022893C2 (nl) 2004-07-13
GB0306944D0 (en) 2003-04-30
GB2398566A (en) 2004-08-25
AU2003203580A1 (en) 2004-07-29
AU2003222765A1 (en) 2004-08-10
WO2004063189A1 (en) 2004-07-29
FIU20030093U0 (fi) 2003-03-06
EP1581519A1 (en) 2005-10-05
US20040198794A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
BE1015847A3 (nl) Vormen van ondansetron en processen voor het maken van deze.
US7459449B2 (en) Stable salts of olanzapine
EP2909191B1 (en) Multicomponent crystalline system comprising nilotinib and selected co-crystal formers
EP0277738B1 (en) Anhdrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
JP7168447B2 (ja) ビラスチンの結晶形態及びそれらの調製方法
US20030191347A1 (en) Venlafaxine base
US6717015B2 (en) Venlafaxine besylate
CA2433366C (en) Amlodipine free base
AU2004238537A1 (en) Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
CN102197035A (zh) 舒尼替尼的结晶形式及其制备方法
EP1636176A2 (en) The polymorphic form a of 4- 6-acetyl-3- 3-(4-acetyl-3- hydroxy-2-propylphenylthio)propoxy -2-propylphenoxy butryric acid
DK200300114U3 (da) Faste tilstandsformer af ondansetron
RU2193560C2 (ru) Новая соль
WO2005000242A2 (en) Process for making polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]butyric acid
US9682988B2 (en) Solid salt form of α-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof
US7335380B2 (en) Amlodipine free base
EP1102764A1 (en) Paroxetine salts
EP1355632A1 (en) Amlodipine free base
EP1951703A2 (en) Desloratadine crystalline forms mixtures having a low level of residual solvents

Legal Events

Date Code Title Description
UBP Utility model lapsed